Prophylactic Cranial Irradiation for Patients with Surgically Resected Small Cell Lung Cancer

The data presented in the current study support using PCI in patients with p-stage II/III disease but not in patients with p-stage I disease. A relatively lower risk for brain metastases in p-stage I patients might explain the inferior efficacy of PCI in this population.